3α-Hydroxy-7-oxo-5β-Asid Kolanik CAS 4651-67-6 Pite> 99.5% (HPLC) Faktori Entèmedyè Obetikolik Asid

Deskripsyon kout:

Non chimik: 3α-Hydroxy-7-oxo-5β-Cholanic asid

CAS: 4651-67-6

Pite:> 99.5% (HPLC)

Poud cristalline blan pou blan poud oswa poud

Entèmedyè asid Obetikolik (CAS: 459789-99-2)

Segondè Kalite, Pwodiksyon Komèsyal

E-Mail: alvin@ruifuchem.com


Pwodwi detay

Pwodwi ki gen rapò

Tags pwodwi

Deskripsyon:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 3α-Hydroxy-7-oxo-5β-Cholanic Acid (CAS: 4651-67-6) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Pwopriyete chimik:

Non Chimik 3α-Idroksi-7-oxo-5β-Asid Kolanik
Sinonim 3α-Idroksi-7-keto-5β-Asid Kolanik;3alpha-Idroksi-7-oxo-5beta-Asid Kolanik;7-Ketolithocholic asid;Ursodeoxycholic Acid EP Enpurite F
Nimewo CAS 4651-67-6
Nimewo CAT RF-PI1988
Estati Stock Nan Stock, Pwodiksyon Echèl Jiska Tòn
Fòmil molekilè C24H38O4
Pwa molekilè 390,56
Dansite 1.124±0.060 g/cm3
Mak Ruifu Chimik

Espesifikasyon:

Atik Espesifikasyon
Aparans Poud oswa poud kristalin blan ak blan;Pa gen sibstans etranje, pa gen okenn odè evidan
Pite / Metòd analiz >99.5% (HPLC)
Pwen k ap fonn 201.0 ~ 205.0 ℃
Pèt sou siye <0.50%
Rezid sou ignisyon <0.20%
Sibstans ki gen rapò
Single enpurte <0.50%
Enpurte total <0.50%
Metal lou ≤10ppm
Spectre proton RMN Konfòm ak estrikti
Tès Creole Enterprise Standard
Itilizasyon Entèmedyè asid Obetikolik (CAS: 459789-99-2)

Pake & Depo:

Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an

Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite

Avantaj:

1

FAQ:

Aplikasyon:

3α-Hydroxy-7-oxo-5β-Cholanic Acid (CAS: 4651-67-6) se yon entèmedyè nan asid Obeticholic (CAS: 459789-99-2).Asid Obetikolik yo rele tou asid 6-Ethylchenodeoxycholic.Asid Obeticholic se yon nouvo derive asid chenodeoxycholic (CDCA) nan asid kòlè prensipal imen, yon ligand natirèl pou reseptè farnesoid x (FXR).Asid Obeticholic te devlope pa konpayi pharmaceutique Ameriken Intercept kòm premye dwòg pou trete maladi fwa kolestatik nan 20 ane, epi li administre sou pasyan ki pa reponn byen oswa ki pa ka tolere ansyen asid ursodeoxycholic tretman estanda dwòg la.Asid Obetikolik yo te teste tou pou trete yon fòm ki pi komen nan fwa gra - maladi fwa gra ki pa alkòl (NAFLD).Asid Obetikolik ka devlope tou pou trete lòt maladi fwa ak trip.

Ekri mesaj ou la a epi voye l ba nou